October 2013 - CONTINUUS Pharmaceuticals

Thursday, October 17th, 2013

ICM Technology featured in Nature

“Integrated Continuous Manufacturing promises to save time and money” Nature 502, 274 (17 October 2013): http://www.nature.com/nature/journal/v502/n7471/full/502274d.html following our recent peer-reviewed scientific publication this month on Angew. Chem. Int.…
Friday, October 4th, 2013

CONTINUUS participates in Industry Executive Panel in Bay Area event for Manufacturing Day

CONTINUUS Pharmaceuticals’ CEO, Salvatore Mascia, participated on a panel discussion with other industry leaders at the Biomedical Manufacturing and Technology Networking Summit in San Francisco on Oct 4 2013.…
Tuesday, October 1st, 2013

Jonathan Fleming and Tom Van Laar to join CONTINUUS Pharmaceuticals advisory board

CONTINUUS Pharmaceuticals is proud to announce two new members of its advisory board.  Jonathan Fleming is the Managing Partner of Oxford Bioscience Partners, and Tom Van Laar is the Former Head of Global Technical Operation at Novartis Pharmaceuticals. More information…